Mathieu Rouanne
Papers
3
Total Citations
2,752
H-Index
2
About
Mathieu Rouanne is a leading urologic oncologist whose research has profoundly shaped the management of muscle-invasive and metastatic bladder cancer. As a key contributor to the European Association of Urology (EAU) Guidelines, his work provides the evidence-based framework for clinical decision-making worldwide. His most influential contribution, the 2020 EAU Guidelines summary, has been cited over 2,100 times, reflecting its critical role in standardizing care for this aggressive disease. Rouanne’s research focuses on optimizing multimodal treatment strategies—integrating radical cystectomy, chemotherapy, and emerging immunotherapies—to improve patient outcomes. He has also been instrumental in updating these guidelines, with the 2023 iteration already accumulating over 600 citations, underscoring the rapid evolution of the field. Beyond guideline authorship, Rouanne’s work advances our understanding of biomarker-driven therapy and personalized medicine in bladder cancer. His contributions have not only informed clinical practice but also set the stage for future innovations in urologic oncology, making him a pivotal figure for students and researchers seeking to understand the current landscape and future directions of bladder cancer treatment.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3